New Drugs in Clinical Development in the United States
作者： John R. Eckardt , Daniel D. Von Hoff
DOI: 10.1016/S0889-8588(18)30175-8
关键词:
摘要: Over the past few years, a number of new antineoplastic agents have reached clinical arena. These demonstrated activity in wide variety preclinical tumor models and many been found to novel mechanisms action. Some these are now Phase I II trials demonstrating antitumor unique toxicity profiles. In this article, authors review some development United States.
sci-hub.se 参考文章(60)
Tannock I, Cell kinetics and chemotherapy: a critical review. Cancer treatment reports. ,vol. 62, pp. 1117- 1133 ,(1978)
Robert H. Earhart, Acivicin: A new antimetabolite Springer, Boston, MA. pp. 161- 181 ,(1987) , 10.1007/978-1-4613-2061-6_7
J. H. Burchenal, Roland Bloch, R. R. Ellison, M. S. Lyman, Donald L. Warkentin, Willi Kreis, Clinical Investigation of the Physiologic Disposition of a Phthalanilide (NSC-38280) and a Phthalamidine Derivative (NSC-57155) in 7 Patients Cancer Research. ,vol. 25, pp. 402- 407 ,(1965)
Donald W. Kufe, Debra Schade, J. Patrick McGovren, Geoffrey R. Weiss, Phase I and Pharmacological Study of Acivicin by 24-Hour Continuous Infusion Cancer Research. ,vol. 42, pp. 3892- 3895 ,(1982)
R Johnson, G Neil, A Bogden, A Ovejera, D Houchens, Therapy of mouse tumors and human tumor xenografts by the antitumor antibiotic at-125 (nsc-163501). Abstr. pp. 40- ,(1978)
Ann E. Berger, Gary L. Neil, Constance L. Blowers, Alexander Bloch, Gerald B. Grindey, Roberto Garza, Richard P. McPartland, Thomas F. DeKoning, Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125). Cancer Research. ,vol. 39, pp. 852- 856 ,(1979)
Manuel Modolell, Reinhard Andreesen, Paul G. Munder, Hans U. Weltzien, Georg W. Löhr, Hansjörg Eibl, Herbert H. Common, Selective Destruction of Human Leukemic Cells by Alkyl-lysophospholipids Cancer Research. ,vol. 38, pp. 3894- 3899 ,(1978)
Kevin J. Clubb, Adel A. Yunis, Robert A. Meck, Larry M. Allen, Inhibition of Cell Cycle Progression of Human Pancreatic Carcinoma Cells in Vitro by l-(αS,5S)-α-Amino-3-chloro-4,5-dihydro-5-isoxazoleacetic Acid, Acivicin (NSC 163501) Cancer Research. ,vol. 41, pp. 4547- 4553 ,(1981)
Wim J. van Blitterswijk, Guy A. Storme, Georges K. De Bruyne, Wolfgang E. Berdel, Eric A. Bruyneel, Marc M. Mareel, Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Research. ,vol. 45, pp. 351- 357 ,(1985)
Ulrich Fink, Wulf Pahlke, Anneliese Reichert, Wolfgang E. Berdel, Uwe Bicker, Michael Fromm, Johann Rastetter, Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin. Cancer Research. ,vol. 43, pp. 5538- 5543 ,(1983)